Skip to main content

Table 4 Univariate and multivariate analyses of overall survival for patients before and after propensity score matching analysis in UICC T3 HCC patients

From: Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

Variable OS before PSM OS after PSM
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
P P HR 95%CI P P HR 95%CI
Age (y), ≥/< 60 0.613     0.131    
Gender (female/male) 0.325     0.776    
Etiology (others/HBV) 0.161     0.296    
PLT (109/L), ≥/<  100 0.994     0.356    
PT (sec), ≥/<  13 0.069 0.047 1.167 1.002–1.359 0.087 0.003 1.425 1.128–1.800
AST (U/L), >/≤ 45 0.019 0.008 1.232 1.055–1.439 0.304    
ALB (g/L), ≥/< 35 0.403     0.058    
TBL (mmol/L), >/≤ 17 0.408     0.937    
(C-P) grade A/B, C 0.400     0.338    
ALBI (grade2–3/ grade 1) 0.027 0.002 1.246 1.084–1.431 0.810    
AFP (ng/mL), ≥/<  400 0.119     0.291    
Tumor size (cm) ≥/<  10 0.016 0.004 1.235 1.071–1.424 0.030 0.003 1.406 1.125–1.757
Tumor numbers (n), > 1/1 0.004 0.004 1.334 1.098–1.620 0.022 0.042 1.435 1.014–2.030
UICC stage IIIb /IIIa 0.000 0.000 1.831 1.545–2.171 0.000 0.000 1.831 1.311–2.559
Year of treatment (10−/−09) 0.056 0.039 0.860 0.746–0.993 0.163    
Initial treatment (HR/TACE) 0.000 0.000 0.677 0.569–0.806 0.000 0.000 0.646 0.522–0.798
  1. Abbreviations: PLT platelet count, PT prothrombin time, AST aspartate aminotransferase, ALB albumin, TBL total bilirubin, (C-P) grade child-Pugh grade, ALBI albumin-bilirubin grade, AFP alpha-fetoprotein, UICC the Union for International Cancer Control, HR hepatic resection, TACE transcarterial chemoembolization, PSM propensity score matching